Humonix Biosciences, Inc.

Humonix Biosciences, Inc. is a specialty pharma research company that is focused on accelerating and de-risking ophthalmic drug development. The company leverages an innovative human tissue engineering platform technology to reduce the cost of drug development. Collaborating with industry and academic partners, Humonix aims to help screen for and identify lead candidates, elucidate their MOA, and validate their efficacy. The company's 3D tissue technology is designed to reduce the risk of clinical trial failure while saving time, labor, and development costs. By enabling the early identification and validation of effective compounds or biologics, Humonix empowers its partners to confidently enter clinical trials. Established in 2015, Humonix Biosciences, Inc. operates within the Biopharma, Biotechnology, and Health Care industries, with its headquarters located in the United States. Currently, there is no available information regarding the last investment or the investors involved.